Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Sargassum fusiforme fraction is a potent and specific inhibitor of HIV-1 fusion and reverse transcriptase.

Paskaleva EE, Lin X, Duus K, McSharry JJ, Veille JC, Thornber C, Liu Y, Lee DY, Canki M.

Virol J. 2008 Jan 15;5:8. doi: 10.1186/1743-422X-5-8.

PMID:
18197976
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection.

Lee DY, Lin X, Paskaleva EE, Liu Y, Puttamadappa SS, Thornber C, Drake JR, Habulin M, Shekhtman A, Canki M.

AIDS Res Hum Retroviruses. 2009 Dec;25(12):1231-41. doi: 10.1089/aid.2009.0019.

PMID:
20001317
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Inhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme.

Paskaleva EE, Lin X, Li W, Cotter R, Klein MT, Roberge E, Yu EK, Clark B, Veille JC, Liu Y, Lee DY, Canki M.

AIDS Res Ther. 2006 May 25;3:15.

PMID:
16725040
[PubMed]
Free PMC Article
4.

Closing two doors of viral entry: intramolecular combination of a coreceptor- and fusion inhibitor of HIV-1.

Kopetzki E, Jekle A, Ji C, Rao E, Zhang J, Fischer S, Cammack N, Sankuratri S, Heilek G.

Virol J. 2008 May 1;5:56. doi: 10.1186/1743-422X-5-56.

PMID:
18452606
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Sphingomyelinase restricts the lateral diffusion of CD4 and inhibits human immunodeficiency virus fusion.

Finnegan CM, Rawat SS, Cho EH, Guiffre DL, Lockett S, Merrill AH Jr, Blumenthal R.

J Virol. 2007 May;81(10):5294-304. Epub 2007 Mar 7.

PMID:
17344303
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

HIV co-receptors as targets for antiviral therapy.

Schols D.

Curr Top Med Chem. 2004;4(9):883-93. Review.

PMID:
15134547
[PubMed - indexed for MEDLINE]
7.

A synthetic CD4-heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry.

Baleux F, Loureiro-Morais L, Hersant Y, Clayette P, Arenzana-Seisdedos F, Bonnaffé D, Lortat-Jacob H.

Nat Chem Biol. 2009 Oct;5(10):743-8. doi: 10.1038/nchembio.207. Epub 2009 Sep 6.

PMID:
19734912
[PubMed - indexed for MEDLINE]
8.

Advanced glycation end products inhibit both infection and transmission in trans of HIV-1 from monocyte-derived dendritic cells to autologous T cells.

Nasreddine N, Borde C, Gozlan J, Bélec L, Maréchal V, Hocini H.

J Immunol. 2011 May 15;186(10):5687-95. doi: 10.4049/jimmunol.0902517. Epub 2011 Apr 8.

PMID:
21478402
[PubMed - indexed for MEDLINE]
Free Article
9.

Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.

Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.

PMID:
19446658
[PubMed - indexed for MEDLINE]
10.

CCR5 antagonist TD-0680 uses a novel mechanism for enhanced potency against HIV-1 entry, cell-mediated infection, and a resistant variant.

Kang Y, Wu Z, Lau TC, Lu X, Liu L, Cheung AK, Tan Z, Ng J, Liang J, Wang H, Li S, Zheng B, Li B, Chen L, Chen Z.

J Biol Chem. 2012 May 11;287(20):16499-509. doi: 10.1074/jbc.M112.354084. Epub 2012 Mar 23.

PMID:
22447925
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmission.

Qiu M, Wang Q, Chu Y, Yuan Z, Song H, Chen Z, Wu Z.

PLoS One. 2012;7(4):e35906. doi: 10.1371/journal.pone.0035906. Epub 2012 Apr 27.

PMID:
22558266
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Specific reactions between purified HIV-1 particles and CD4+ cell membrane fragments in a cell-free system of virus fusion or entry.

Harada T, Tatsumi M, Takahashi H, Sata T, Kurata T, Kojima A.

Microbes Infect. 2004 Apr;6(5):421-8.

PMID:
15109956
[PubMed - indexed for MEDLINE]
14.

Selective HIV-1-induced downmodulation of CD4 and coreceptors.

Chenine AL, Sattentau Q, Moulard M.

Arch Virol. 2000;145(3):455-71.

PMID:
10795515
[PubMed - indexed for MEDLINE]
15.

Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.

De Clercq E, Schols D.

Antivir Chem Chemother. 2001;12 Suppl 1:19-31.

PMID:
11594685
[PubMed - indexed for MEDLINE]
16.

Role of CXCR4 in cell-cell fusion and infection of monocyte-derived macrophages by primary human immunodeficiency virus type 1 (HIV-1) strains: two distinct mechanisms of HIV-1 dual tropism.

Yi Y, Isaacs SN, Williams DA, Frank I, Schols D, De Clercq E, Kolson DL, Collman RG.

J Virol. 1999 Sep;73(9):7117-25.

PMID:
10438797
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Highly potent chimeric inhibitors targeting two steps of HIV cell entry.

Zhao B, Mankowski MK, Snyder BA, Ptak RG, Liwang PJ.

J Biol Chem. 2011 Aug 12;286(32):28370-81. doi: 10.1074/jbc.M111.234799. Epub 2011 Jun 9.

PMID:
21659523
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

A low-molecular-weight entry inhibitor of both CCR5- and CXCR4-tropic strains of human immunodeficiency virus type 1 targets a novel site on gp41.

Murray EJ, Leaman DP, Pawa N, Perkins H, Pickford C, Perros M, Zwick MB, Butler SL.

J Virol. 2010 Jul;84(14):7288-99. doi: 10.1128/JVI.00535-10. Epub 2010 Apr 28.

PMID:
20427524
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The role of receptors in the HIV-1 entry process.

Jones R, Nelson M.

Eur J Med Res. 2007 Oct 15;12(9):391-6. Review.

PMID:
17933719
[PubMed - indexed for MEDLINE]
20.

The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.

Waters L, Mandalia S, Randell P, Wildfire A, Gazzard B, Moyle G.

Clin Infect Dis. 2008 May 15;46(10):1617-23. doi: 10.1086/587660.

PMID:
18419499
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk